UniFAHS Raises USD1.4 Million in Seed Backing to Scale Bacteriophage Technology for Sustainable Agriculture
UniFAHS, a trailblazing biotechnology company specialising in phage technology for sustainable husbandry and food safety, moment blazoned it has raised over USD1.4 million in its seed backing round. This significant step propels the company forward in its charge of growth and transubstantiating food product using environmentally friendly and sustainable approaches.
The backing round, led by A2D gambles and supported by benefactions from Asian Development Bank gambles( ADB Ventures) and InnoSpace( Thailand), underscores the strong confidence in UniFAHS’s innovative approach and unborn eventuality. A2D Ventures is a prominent community- led early- stage investing platform that aims to attack fragmentation and democratise access to investment openings.
” We’re thrilled to lead and syndicate this strategic investment occasion in UniFAHS, recognising the solidarity between their groundbreaking technology and the authors’ scientific prowess. This investment underscores our confidence in Thai authors and Thailand- grounded startups’ implicit to review and recreate diligence, offering results that can be exported to global requests and achieve substantial growth snappily,” says Ankit Upadhyay, Author and CEO of A2D gambles.
Co-founded by Dr Kitiya Vongkamjan, a distinguished Cornell University alumna and leading figure in phage exploration and food safety, and Chalita Wongpukdee, who brings moxie in agribusiness marketing and deals with expansive connections in husbandry, food, feed, and beast health, UniFAHS’s patented phage results are at the van of combating antimicrobial resistance( AMR) and promoting climate-friendly agrarian practices. Dr Vongkamjan shares,” Our vision at UniFAHS is to produce a sustainable future for food product. This backing is a fiscal boost and a strong countersign of our phage technology’s implicit to revolutionise the husbandry and food safety sectors.”
Recognised as one of the Top 10 Beast operation startups encyclopedically by StartUs perceptivity in 2023, Dr Vongkamjan and her platoon continue to further groundbreaking exploration and sustainable food product to review the biotechnology geography. This investment serves as a catalyst that will enable the company to expand its product capacity and extend its reach across Southeast and South Asia by working nearly with its distribution mates to expand the client parts by 20 in 2024 to impact the world’s food product significantly.
As UniFAHS embarks on a trip of growth and expansion, ADB Ventures has surfaced as a critical mate, contributing fiscal support and a wealth of experience and global connections – with both companies participating a united commitment to prioritising environmentally friendly and socially responsible practices in the pursuit of profitable growth.
” UniFAHS’s innovative results represent a transformative occasion in the husbandry and food sectors, significantly reducing our dependence on antibiotics. We believe UniFAHS has the implicit to make a considerable impact on the climate in the region. We’re enthusiastic about supporting UniFAHS’s expansion across Asia,” expressed Thitirat Sittakaradej, Investment Specialist at ADB gambles.
To date, UniFAHS has successfully secured hookups with the world’s top flesh directors in the region. By employing the power of phages, UniFAHS offers a game- changing approach to addressing pressing challenges for bacterial control and diving antimicrobial resistance issues in husbandry and beast health.
InnoSpace( Thailand) also emphasised its strategic commitment” Our investment in UniFAHS is driven by a commitment to fostering sustainable results for global challenges. We’re agitated to support UniFAHS’s trip to empower the platoon to expedite developing and planting its slice- edge phage results.”
About UniFAHS
UniFAHS is a colonist in applying phage technology, icing the sustainable product of safe foods from ranch to chopstick, promoting the holistic conception of” One Health”, and laboriously combating the global challenge of antimicrobial resistance. The company is devoted to shaping a brighter and further sustainable future through slice- edge phage technology to enhance the well- being of communities and ecosystems as a” One- Health” approach.
